Related Experiment Video
Updated: Jan 12, 2026

04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
1.2K
Psilocybin use in bipolar disorder: A comprehensive review
André Do1, Laurence Cloutier2, Lydia Hébert-Tremblay1
1Department of Psychiatry, Université de Montréal, Montreal, QC, Canada.
Journal of Affective Disorders
|November 2, 2025
Summary
Psilocybin shows promise for bipolar depression treatment, with early trials indicating safety and effectiveness. However, further research is needed to confirm its therapeutic value and fully understand potential risks in bipolar disorder patients.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Bipolar disorder (BD) is a severe mental illness with high burden from depression.
- Current treatments like mood stabilizers and antipsychotics have limited efficacy and side effects.
- Novel, safe, and effective treatments for bipolar depression are urgently needed.
Purpose of the Study:
- To review the clinical outcomes of psilocybin use in bipolar disorder (BD).
- To assess the safety and efficacy of psilocybin as a potential treatment for BD depression.
Main Methods:
- Comprehensive narrative review of existing literature.
- Focus on clinical trials and reported outcomes of psilocybin in BD patients.
Main Results:
- Two small trials suggest psilocybin with psychotherapy is safe and effective for BDII depression.
- No serious adverse events like mania or increased suicidality were reported in these trials.
- Other studies indicate potential risks including manic symptoms, sleep issues, and anxiety; patient experiences vary with context.
Conclusions:
- Psilocybin shows potential for treating bipolar depression but its efficacy and safety are not yet clear.
- More research is essential to determine the therapeutic value of psilocybin in bipolar disorder.
- Understanding contextual factors is crucial for safe and effective psilocybin administration in BD.
Related Concept Videos
Mania and Antimanic Drugs: Overview
540
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
540
Bipolar Disorder
611
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
611
Psychosis: Goals of Pharmacotherapy
457
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
457
Psychosis and Antipsychotic Drugs: Overview
795
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
795
Hallucinogens and Psychedelics
584
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
584
Drug Therapy
237
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
237

